BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 4414663)

  • 1. Methyldopa liver damage.
    Toghill PJ; Smith PG; Benton P; Brown RC; Matthews HL
    Br Med J; 1974 Aug; 3(5930):545-8. PubMed ID: 4414663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis induced by methyldopa (aldomet). Report of a case and a review of the literature.
    Tysell JE; Knauer M
    Am J Dig Dis; 1971 Sep; 16(9):848-55. PubMed ID: 5098212
    [No Abstract]   [Full Text] [Related]  

  • 3. Patterns of hepatic injury induced by methyldopa.
    Seggie J; Saunders SJ; Kirsch RE; Campbell JA; Gitlin N; Clain D; Terblanche J
    S Afr Med J; 1979 Jan; 55(3):75-83. PubMed ID: 424937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic injury caused by L-alpha-methyldopa.
    Elkington SG; Schreiber WM; Conn HO
    Circulation; 1969 Oct; 40(4):589-95. PubMed ID: 5823554
    [No Abstract]   [Full Text] [Related]  

  • 5. Methyldopa-induced submassive hepatic necrosis.
    Rehman OU; Keith TA; Gall EA
    JAMA; 1973 Jun; 224(10):1390-2. PubMed ID: 4739987
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute submassive hepatic necrosis due to methyldopa. A case demonstrating possible initiation of chronic liver disease.
    Schweitzer IL; Peters RL
    Gastroenterology; 1974 Jun; 66(6):1203-11. PubMed ID: 4133500
    [No Abstract]   [Full Text] [Related]  

  • 7. Methyldopa Hepatitis. A report of six cases and review of the literature.
    Rodman JS; Deutsch DJ; Gutman SI
    Am J Med; 1976 Jun; 60(7):941-8. PubMed ID: 937354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatic injury caused by methyldopa in a pre-eclamptic patient].
    Minakami H; Ohkusa T; Kimura K; Tamada T; Hirota N
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):139-42. PubMed ID: 3950462
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatotoxicity due to treatment with papaverine. Report of four cases.
    Ronnov-Jessen V; Tjernlund A
    N Engl J Med; 1969 Dec; 281(24):1333-5. PubMed ID: 5355438
    [No Abstract]   [Full Text] [Related]  

  • 10. Methyldopa-induced liver injury. Rapid progression to fatal postnecrotic cirrhosis.
    Thomas E; Bhuta S; Rosenthal WS
    Arch Pathol Lab Med; 1976 Mar; 100(3):132-5. PubMed ID: 946400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxyphenisatin and liver damage.
    Willing RL; Hecker R
    Med J Aust; 1971 May; 1(22):1179-82. PubMed ID: 5557089
    [No Abstract]   [Full Text] [Related]  

  • 12. Spectrum of methyldopa liver injury.
    Thomas E; Rosenthal WS; Zapiach L; Micci D
    Am J Gastroenterol; 1977 Aug; 68(2):125-33. PubMed ID: 920711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jaundice and oxyphenisatin.
    McHardy G; Balart LA
    JAMA; 1970 Jan; 211(1):83-5. PubMed ID: 5466895
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe hepatitis from methyldopa.
    Maddrey WC; Boitnott JK
    Gastroenterology; 1975 Feb; 68(2):351-60. PubMed ID: 22550758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlations in alcoholic patients without manifest cirrhosis.
    Bordalo O; Batista A; Geraldes J; Neto F; Mascarenhas F; Leitao N; Noronha M; Lamy J; Silva PE
    Am J Gastroenterol; 1974 May; 61(5):371-8. PubMed ID: 4835934
    [No Abstract]   [Full Text] [Related]  

  • 16. [Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
    Austerhoff A; Kindler U; Knop P; Knieriem HJ
    Dtsch Med Wochenschr; 1974 May; 99(22):1182 p. PubMed ID: 4835559
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic aggressive hepatitis after methyldopa treatment. Case report with electron-microscopic study.
    Balázs M; Kovách G
    Hepatogastroenterology; 1981 Aug; 28(4):199-202. PubMed ID: 7274982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver toxicity of a new anabolic agent: methyltrienolone (17-alpha-methyl-4,9,11-estratriene-17 beta-ol-3-one).
    Krüskemper HL; Noell G
    Steroids; 1966 Jul; 8(1):13-24. PubMed ID: 5955468
    [No Abstract]   [Full Text] [Related]  

  • 19. [Occurrence of pathologic liver function tests in anicteric drug addicts].
    Weizel A; Linhart P; Kommerell B; Heilmann K
    Dtsch Med Wochenschr; 1973 May; 98(20):1222-5. PubMed ID: 4707657
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differential diagnosis of aminazine jaundice and viral hepatitis developing during aminazine treatment].
    Sinaĭko GA; Paktoris EA; Pozdniakova SL; Kutchak SN; Shumkina OB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Jan; 72(1):112-7. PubMed ID: 5020147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.